Interestingly, despite C1Q being the initiating protein in the classical complement cascade and, thus, acting to promote activation/cleavage of C3 to iC3b, its levels were not altered with disease stage in the CSF of patients with HD, and it showed no association with CAP score (Extended Data Fig. 10a,b). This evidence concerns the gene C3 and Huntington disease.